Opening Asia for Russia

Kazakhstan registers domestically produced Sputnik V

15.02.2021 38 просмотров

The Sputnik V vaccine, produced in the republic, has been registered in Kazakhstan.

Kazakh authorities have registered the Sputnik V vaccine, produced on the basis of the Karaganda Pharmaceutical Complex (KPC). This was announced on Monday by the interdepartmental commission for the prevention of the spread of coronavirus under the government of the republic.

“The Karaganda Pharmaceutical Complex has completed the procedure for registering the vaccine against coronavirus infection Gam-kovid-vak (Sputnik-V) on the territory of the Republic of Kazakhstan ”, the report says.

According to the press service of the pharmaceutical complex, on February 13, a conclusion was received from an expert organization of the Ministry of Health of Kazakhstan on the safety, quality and effectiveness of the vaccine. “Based on this conclusion, an application for obtaining a registration certificate was sent to the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic. Thus, Kazakhstan became the 27th country that approved the use of the Sputnik V vaccine, the interdepartmental commission explained.

According to preliminary calculations, about 90 thousand doses of the vaccine will be delivered to all regions of the country by the end of February "Sputnik V" produced by KFK.

In January, an experimental batch of the vaccine "Sputnik V", produced by KFK, was successfully tested at the National Research Center for Epidemiology and Microbiology. Gamaleya. On January 27, the First Vice Minister of Health of Kazakhstan Marat Shoranov announced that KFK had begun production of the first batch of the vaccine.

On February 1, vaccination of the population against coronavirus infection using the Sputnik V vaccine began in Kazakhstan which is made in Russia. After registration in the republic of the drug "Sputnik V", produced on the basis of KFK, it will also be used for vaccination. Starting from the second quarter, the Kazakh-made vaccine QazCovid-in (“Kazkovid-in”), which is currently undergoing the third phase of clinical trials, is also going to be used in this process.

Новости партнёров